About GridAI Technologies Corp.
https://www.grid-ai.comGridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
CEO
Jason David Sawyer
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-08-18 | Reverse | 1:3 |
| 2023-12-18 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-
Price Target
About GridAI Technologies Corp.
https://www.grid-ai.comGridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $934.79K ▲ | $-1.15M ▼ | 0% | $-0.75 ▼ | $-934.79K ▼ |
| Q2-2025 | $0 | $638.86K ▼ | $-998.27K ▲ | 0% | $-0.21 ▲ | $-638.86K ▲ |
| Q1-2025 | $0 ▼ | $821.39K ▼ | $-1.26M ▲ | 0% ▲ | $-0.28 ▲ | $-930.2K ▲ |
| Q4-2024 | $95.78K ▲ | $1.2M ▼ | $-12.24M ▼ | -12.78K% ▼ | $-2.59 ▼ | $-1.24M ▲ |
| Q3-2024 | $0 | $1.89M | $-2.58M | 0% | $-0.59 | $-1.89M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $2.52M ▲ | $135.37M ▲ | $45.81M ▲ | $84.28M ▲ |
| Q2-2025 | $4.47K ▼ | $85.06M ▼ | $29.68M ▲ | $55.38M ▼ |
| Q1-2025 | $59.35K ▼ | $85.2M ▼ | $28.74M ▲ | $56.46M ▼ |
| Q4-2024 | $163.48K ▼ | $85.41M ▼ | $27.61M ▲ | $57.8M ▼ |
| Q3-2024 | $366.79K | $85.82M | $15.77M | $70.05M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-1.15M ▼ | $-855.69K ▼ | $336.43K ▲ | $3.02M ▲ | $2.51M ▲ | $-855.69K ▼ |
| Q2-2025 | $-998.27K ▲ | $-54.88K ▲ | $0 | $0 ▼ | $-54.88K ▲ | $-54.88K ▲ |
| Q1-2025 | $-1.26M ▲ | $-818.63K ▼ | $0 | $700K ▲ | $-118.64K ▲ | $-818.63K ▼ |
| Q4-2024 | $-12.24M ▼ | $-171.52K ▲ | $0 | $-31.8K ▼ | $-203.32K ▲ | $-171.52K ▲ |
| Q3-2024 | $-2.58M | $-1.85M | $0 | $1.55M | $-295.69K | $-1.85M |
CEO
Jason David Sawyer
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-08-18 | Reverse | 1:3 |
| 2023-12-18 | Reverse | 1:20 |
ETFs Holding This Stock
Summary
Showing Top 1 of 1
Ratings Snapshot
Rating : B-